There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
The apparent failure of global health security to prevent or prepare for the COVID-19 pandemic has highlighted the need for closer cooperation between human, animal (domestic and wildlife), and environmental health sectors. However, the many institutions, processes, regulatory frameworks, and legal instruments with direct and indirect roles in the global governance of One Health have led to a fragmented, global, multilateral health security architecture. We explore four challenges: first, the sectoral, professional, and institutional silos and tensions existing between human, animal, and environmental health; second, the challenge that the international legal system, state sovereignty, and existing legal instruments pose for the governance of One Health; third, the power dynamics and asymmetry in power between countries represented in multilateral institutions and their impact on priority setting; and finally, the current financing mechanisms that predominantly focus on response to crises, and the chronic underinvestment for epidemic and emergency prevention, mitigation, and preparedness activities. We illustrate the global and regional dimensions to these four challenges and how they relate to national needs and priorities through three case studies on compulsory licensing, the governance of water resources in the Lake Chad Basin, and the desert locust infestation in east Africa. Finally, we propose 12 recommendations for the global community to address these challenges. Despite its broad and holistic agenda, One Health continues to be dominated by human and domestic animal health experts. Substantial efforts should be made to address the social-ecological drivers of health emergencies including outbreaks of emerging, re-emerging, and endemic infectious diseases. These drivers include climate change, biodiversity loss, and land-use change, and therefore require effective and enforceable legislation, investment, capacity building, and integration of other sectors and professionals beyond health.
Since COVID-19 was first discovered, it exploded into a pandemic resulting in devastating effects on human lives and a global recession. While there have been discussions that COVID-19 will accelerate the ‘end of globalization and multilateralism’, we have already seen the high costs of non-cooperation in responding to the virus resulting in sub-optimal use of resources, rapid spread of the virus between countries, and, ultimately, significant loss of life. In spite of their favorable demographic structures and relatively young populations, countries in the Global South are still harshly affected in both epidemiological and economic terms. Nations must find innovative ways to address health concerns and regional bodies are possible mechanisms for facilitating international cooperation on health. We delineate how regional organizations can support how countries address health threats namely by serving as a bridge between the global and national policy levels; strengthening disease surveillance; mobilizing supply chains and facilitating trade; supporting the production and procurement of medicines and supplies; and coordinating policies and work with other actors. We finalize by arguing that mechanisms for regional cooperation must be strengthened themselves in order to effectively contribute to positive health outcomes within member states.
Publisher:
Public Library of Science
(San Francisco, CA USA
)
ISSN
(Electronic):
2767-3375
Publication date
(Electronic):
2
January
2025
Publication date Collection: 2025
Volume: 5
Issue: 1
Electronic Location Identifier: e0003985
Affiliations
[1
]
Saw Swee Hock School of Public Health, National University of Singapore, Singapore,
Singapore
[2
]
UK Health Security Agency, Jakarta, Indonesia
[3
]
Foundation for Innovative New Diagnostics, Geneva, Switzerland
[4
]
O’Neill Institute for National and Global Health Law, Georgetown University, Washington,
D.C., United States of America
[5
]
Department of Disease Control, Ministry of Public Health, Bangkok, Thailand
[6
]
Asia Centre for Health Security, Singapore, Singapore
[7
]
Department of Health, Manila, Philippines
[8
]
Reaching the Last Mile Foundation, Nairobi, Kenya
[9
]
London School of Hygiene and Tropical Medicine, London, United Kingdom
[10
]
Ministry of Health, Bandar Seri Begawan, Brunei Darussalam
[11
]
Health Division, ASEAN Secretariat, Jakarta, Indonesia
PLOS: Public Library of Science, UNITED STATES OF AMERICA
Author notes
I have read the journal’s policy and the authors of this manuscript have the following
competing interests: AR holds a position with the UK Health Security Agency, which
engages with regional organizations, including ASEAN and Africa CDC. SH, ZJMH, IM,
and JW hold positions with their respective ministries of health in ASEAN Member States,
and thus engage with various platforms and mechanisms coordinated by the ASEAN Health
Division (see
Table 1). FF is the former Assistant Director and Head of the Health Division at ASEAN (2011-24).
Within five years from the time of writing, EO has been an honorary advisor to the
Director-General of the Africa CDC (2019-22); IA was the former Director-General of
Nigeria CDC (2021-24), and OO was a former Technical Assistant at Nigeria CDC (2016-20).
This does not alter our adherence to PLOS Global Public Health’s policies on sharing
data and materials. There are no patents, products in development or marketed products
associated with this research to declare.
‡ ARS and AR are joint first authors on this work.
This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original author and source are credited.
History
Page count
Figures: 1,
Tables: 1,
Pages: 5
Funding
The authors received no specific funding for this work.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.